Accordingly, Thomson Medical is now in compliance with Rule 723 of SGX-ST’s listing manual.
The company’s public float first fell below 10% in September last year, and received three months to restore its public float.
Subsequently, the company received an additional one month to restore the public float before a final three month extension was granted in January after initially being rejected by SGX-ST.
Shares in Thomson Medical closed unchanged at 5.4 cents on April 4.
